Catapulted by the announcement of the Human Genome Project's 90 percent completion of mapping the human genome, the bio technology industry has begun to gain rapid international recognition..
Despite the far-reaching future potential for this rapidly emerging high-tech industry, the nation's bio-tech businesses have remained at a``laboratory venture'' level, unable to develop own products due primarily to a lack of an appropriate climate and other software assistance.
Some firms in the industry once raised increasing concerns, flexing muscle at the KOSDAQ market, making up the mainstay group of promising items.
However, the majority have ended up failing to …